PHI partners with University College London to use HoloMonitor in a first clinical research project
Phase Holographic Imaging (PHI) is excited to announce a strategic partnership with University College London (UCL). Under this collaboration, PHI will lend a HoloMonitor® M4FL system for use in an ongoing research project at UCL, which runs alongside a clinical trial. This partnership represents PHI's first direct step in a hospital setting to explore the clinical applications of its innovative technology.Patrik Eschricht, CEO of PHI, comments: “Our HoloMonitor system provides detailed cell information to assess the quality of individual cell samples. Imagine a future where researchers